Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Beclometasone vs placebo

Adverse events: candidiasis · participants with stable stage 2 and 3 COPD (mainly FEV1 49 ± 12% predicted), ex‐smokers (majority), smokers and non‐smokers

It is very uncertain whether beclometasone changes adverse events: candidiasis compared with placebo (very low certainty).

1 finding from 1 review

Beclometasone for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
OR 1.41 [0.24, 8.31]
1 study · 194 participants
Very low

Beclometasone/LABA vs LABA

Adverse events: candidiasis · participants with stable stage 3 COPD, smokers and ex‐smokers with a minimum pack‐year history of 20

1 finding from 1 review

Beclometasone for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 474 participants
Moderate